儿童状细胞疾病中的社会经济地位和中风风险:一个失位研究二次分析
Jeffrey G Edwards1, Daniel T Humphrey2, Martina Mueller2
1Department of Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Pediatric blood & cancer
|October 14, 2025
概括
基尿素处方,而不是社会经济地位,显著影响状细胞疾病 (SCD) 的儿童的异常跨骨多普勒 (TCD) 结果. 这凸显了HU治疗对SCD患者中风风险评估的重要性.
科学领域:
- 儿科血液学 儿科血液学
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 跨皮多普勒 (TCD) 查识别了状细胞疾病 (SCD) 的儿童中风风险.
- 社会经济地位 (SES) 可能会影响获得医疗保健和TCD结果,但这种联系尚未得到充分证实.
- 以前的研究表明,低机会社区的公共保险家庭存在障碍.
研究的目的:
- 调查社会经济地位 (SES) 与状多普勒 (TCD) 查结果在患有状细胞疾病 (SCD) 的儿童之间的关联.
- 确定影响儿科SCD患者异常或有条件TCD结果的因素.
主要方法:
- 对DISPLACE研究数据的二次分析 (2-6岁儿童).
- 使用的保险类型和童年机会指数 (COI) 来代表家庭和社区SES.
- 研究了SES代理和TCD查结果之间的关联.
主要成果:
- 这项研究包括3124名儿童,41.5%居住在非常低的COI社区,64.6%有公共保险.
- 缺少氧尿素 (HU) 处方与异常的TCD结果密切相关 (aOR = 19.01,p < 0.001).
- 低SES代理与异常或有条件的TCD结果没有独立相关.
结论:
- 水氧尿素 (HU) 处方是与SCD儿童异常TCD结局相关的最重要因素.
- 社会经济地位没有独立预测异常的TCD结果.
- 需要进一步进行定性研究,以了解儿科SCD护理中HU处方的障碍.
相关概念视频
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
252
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
192
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
242
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242